1. Home
  2. NRSN vs DUO Comparison

NRSN vs DUO Comparison

Compare NRSN & DUO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • DUO
  • Stock Information
  • Founded
  • NRSN 2017
  • DUO 2011
  • Country
  • NRSN Israel
  • DUO China
  • Employees
  • NRSN N/A
  • DUO N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • DUO Real Estate
  • Sector
  • NRSN Health Care
  • DUO Finance
  • Exchange
  • NRSN Nasdaq
  • DUO Nasdaq
  • Market Cap
  • NRSN 17.8M
  • DUO 17.1M
  • IPO Year
  • NRSN 2021
  • DUO 2019
  • Fundamental
  • Price
  • NRSN $1.12
  • DUO $0.40
  • Analyst Decision
  • NRSN Hold
  • DUO
  • Analyst Count
  • NRSN 1
  • DUO 0
  • Target Price
  • NRSN N/A
  • DUO N/A
  • AVG Volume (30 Days)
  • NRSN 129.6K
  • DUO 2.7M
  • Earning Date
  • NRSN 04-04-2025
  • DUO 04-17-2025
  • Dividend Yield
  • NRSN N/A
  • DUO N/A
  • EPS Growth
  • NRSN N/A
  • DUO N/A
  • EPS
  • NRSN N/A
  • DUO N/A
  • Revenue
  • NRSN N/A
  • DUO $37,352,654.00
  • Revenue This Year
  • NRSN N/A
  • DUO N/A
  • Revenue Next Year
  • NRSN N/A
  • DUO N/A
  • P/E Ratio
  • NRSN N/A
  • DUO N/A
  • Revenue Growth
  • NRSN N/A
  • DUO 6.61
  • 52 Week Low
  • NRSN $0.51
  • DUO $0.32
  • 52 Week High
  • NRSN $2.25
  • DUO $4.67
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 51.47
  • DUO 28.03
  • Support Level
  • NRSN $0.96
  • DUO $0.40
  • Resistance Level
  • NRSN $1.17
  • DUO $0.55
  • Average True Range (ATR)
  • NRSN 0.08
  • DUO 0.04
  • MACD
  • NRSN 0.00
  • DUO -0.01
  • Stochastic Oscillator
  • NRSN 66.24
  • DUO 7.05

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About DUO Fangdd Network Group Ltd.

Fangdd Network Group Ltd is an investment holding company. Through its subsidiaries, It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.

Share on Social Networks: